Immunotherapy is continuously revolutionizing outcome in patients with melanoma, making noninvasive and highly effective local treatments for brain metastases more relevant, even if the benefits and risks of the combination of radiotherapy with BRAF-targeted agents are also yet to be established. Here, BRAF is linked to melanoma.